Geninthiocins E and F, two new cyclic thiopeptides with antiviral activities from soil-derived Streptomyces sp. CPCC 200267 using OSMAC strategy

J Antibiot (Tokyo). 2023 Feb;76(2):101-104. doi: 10.1038/s41429-022-00580-0. Epub 2022 Nov 25.

Abstract

On the basis of the one strain-many compounds (OSMAC) strategy, two new cyclic thiopeptides, geninthiocins E and F, together with four known geninthiocin derivatives, geninthiocins A, B, C, and val-geninthiocin were isolated from Streptomyces sp. CPCC 200267. Their structures and absolute configurations were elucidated by extensive spectroscopic analyses and Marfey's method. Geninthiocin E (1), val-geninthiocin (3), geninthiocin A (4), and geninthiocin B (5) exhibited significant anti-influenza A virus activities with the IC50 values of 28.7, 15.3, 7.3, and 18.3 μM, respectively. Compounds 3 and 4 showed moderate antibacterial activities against Staphylococcus aureus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Antiviral Agents* / pharmacology
  • Molecular Structure
  • Peptides, Cyclic / chemistry
  • Streptomyces* / chemistry

Substances

  • Anti-Bacterial Agents
  • Antiviral Agents
  • geninthiocin
  • Peptides, Cyclic
  • geninthiocin B
  • geninthiocin A